Addus HomeCare Corp. (ADUS) is a publicly traded Healthcare sector company. As of July 21, 2026, ADUS trades at $112.06 with a market cap of $2.14B and a P/E ratio of 26.55. ADUS moved +0.39% today. Year to date, ADUS is +2.64%; over the trailing twelve months it is +4.18%. Its 52-week range spans $87.95 to $136.72. Analyst consensus is strong buy with an average price target of $131.56. Rallies surfaces ADUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ADUS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $112.06 |
| Market Cap | $2.14B |
| P/E Ratio | 26.55 |
| EPS | $4.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $136.72 |
| 52-Week Low | $87.95 |
| Volume | 153.19K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.15B |
| Net Income | $73.60M |
| Gross Margin | 32.48% |
12 analysts cover ADUS: 0 strong buy, 10 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $131.56.